Cue Biopharma Announces Publication in The Journal of Clinical Investigation Highlighting Immuno-STAT Biologics for the Treatment of Chronic Infectious Diseases

NEXT STORY
Signature HealthCARE Wins Gold and Top Honors in McKnight’s Excellence in Technology Awards
PREV STORY
Urinalysis Market Size ($5,937.97Mn by 2028) Lead by Sediment Urinalysis Test (5.6% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innate Pharma appoints experts to new Strategic Advisory Board

Innate PHARMA APPOINTS EXPERTS TO NEW strategic advisory board Marseille, France, November 20, 2018, ...

author_avatar
NASDAQ Market News

pSivida’s Second Phase 3 Study for Durasert™ Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months

Highly Significant Difference Between Durasert and Sham in Prevention of Uveitis Recurrence at 12 Months ...

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

BERKELEY HEIGHTS, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" ...

author_avatar
NASDAQ Market News